WiseGuyRerports.com Presents “Global Hemato Oncology Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024” New Document to its Studies Database
Blood cancer, or hematologic malignancies, are one of the most fatal and malignant types of cancer in terms of incidents and cause of death. They constitute over 9% of cancer cases diagnosed in a year. Hemato oncology testing involves the analysis of the blood composition and detection of anomalies such as sickle cells, low iron content (anemia), leukemia, and lymphomas. In this discipline of medicine, blood testing experts (hematologists) and cancer experts (oncologists) conduct tests on the blood samples and attempt to treat or decipher more information related to blood or bone marrow cancer.
Due to the increasing instances of cancer, the hemato oncology testing market is projected to grow at a CAGR of 14.8% and reach a valuation of USD 4 billion. The growing awareness of cancer and cancer-related diseases, along with the increase in demand for personalized medicines, are also responsible for driving up this market.
Key Players
MolecularMD
Invivoscribe
QIAGEN N.V.
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Adaptive Biotechnologies
Illumina
Bio-Rad Laboratories
Asuragen
ArcherDx
ARUP Laboratories
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4501795-global-hemato-oncology-testing-market-2019-by-company
Segmentation
Based on the testing capacity of the hemato oncology testing equipment, the market may be segmented as Leukemia testing, Acute myeloid testing, Multiple myeloma testing, and others. Further, the industry can also be divided on the basis of the setting where the testing equipment is being used, the primary ones being clinical laboratories and hospitals.
Regional Analysis
On the basis of the geographic location, the region-wise segmentation of the market can be carried out in the following manner:
The North American market is expected to dominate the hemato oncology testing market for the forecast period. This is a result of the growing incidents of hematologic cancer cases in the region. Due to various government initiatives that are working in favor of increasing awareness regarding blood-related diseases, the Asia-Pacific market also promises a growing trend.
Industry News
Hoffman-La Roche Limited, a well-known global biotech company, is working in the field of development, manufacture, marketing, and sale of pharmaceutical and biopharmaceutical products and services. The company has launched products like the Coba m 511 analyzer, which is categorized as a consumer electronics grade hemato oncology tester.
Make Enquiry Details @ https://www.wiseguyreports.com/enquiry/4501795-global-hemato-oncology-testing-market-2019-by-company
Table Of Content:
1 Market Overview
2 Manufacturers Profiles
3 Global Market Competition, by Players
4 Global Market Size by Regions
5 North America Revenue by Countries
6 Europe Revenue by Countries
7 Asia-Pacific Revenue by Countries
8 South America Revenue by Countries
9 Middle East and Africa Revenue by Countries
10 Global Market Segment by Type
11 Global Market Segment by Application
12 Global Market Size Forecast (2019-2024)
13 Research Findings and Conclusion